Efficacy and safety of tyrosine kinase inhibitors alone or in combination with radiation therapy for metastatic renal cell carcinoma: A protocol for evidence-based systematic review and Bayesian network meta-analysis

BACKGROUND: Given the lack of evidence for survival benefit in patients with metastatic renal cell carcinoma from the addition of radiation therapy to tyrosine kinase inhibitor therapy, this Bayesian network meta-analysis aimed to evaluate survival outcomes in patients receiving radiation therapy pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shihua, Jin, Weihua, Jiang, Changqing, Zhang, Yiwen, Deng, Kaiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376327/
https://www.ncbi.nlm.nih.gov/pubmed/34414990
http://dx.doi.org/10.1097/MD.0000000000027004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376327/
https://www.ncbi.nlm.nih.gov/pubmed/34414990
http://dx.doi.org/10.1097/MD.0000000000027004

Ejemplares similares